144
Neurogene Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
84.7
FY23:
200
FY24:
316
FY25:
272
(positive)
Change from FY21 to FY25
millions USD
FY21:
19.3
FY22:
24.5
FY23:
22.2
FY24:
19.8
FY25:
16.8
Total assets
Change from FY21 to FY25
millions USD
FY21:
163
FY22:
109
FY23:
223
FY24:
336
FY25:
289
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
8.64
FY22:
6.65
FY23:
23.0
FY24:
15.2
FY25:
16.4
(negative)
Change from FY21 to FY25
millions USD
FY21:
11.8
FY22:
3.99
FY23:
13.6
FY24:
10.2
FY25:
7.31
(positive)
Change from FY21 to FY25
millions USD
FY21:
143
FY22:
−146
FY23:
186
FY24:
310
FY25:
265
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
163
FY22:
–
FY23:
223
FY24:
336
FY25:
289
All amounts in millions USD